Ottawa blocking Canadians’ access to innovative drugs
Health Canada’s revisions to the drug-pricing review board will delay or prevent access to new drugs
Read MorePosted by Nigel Rawson | Jan 18, 2018
Health Canada’s revisions to the drug-pricing review board will delay or prevent access to new drugs
Read MorePosted by The Fraser Institute | Jan 16, 2018
Concerns about density are misplaced – Toronto and Vancouver have plenty of room to grow up and grow more affordable
Read MorePosted by Jason Clemens | Jan 11, 2018
Introducing new regulations and taxes to diminish executive pay will ultimately damage the Canadian economy
Read MorePosted by Ken Green | Dec 27, 2017
The province already lags behind many American states in key policy areas, including regulatory compliance and taxation
Read MorePosted by Jason Clemens | Dec 26, 2017
The 2016 CPP reforms were solutions in search of a problem – and don’t even solve the imagined problem
Read More